Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| Online-Ressource |
Verfasst von: | Notaro, Sara [VerfasserIn]  |
| Altevogt, Peter [VerfasserIn]  |
Titel: | Evaluating L1CAM expression in human endometrial cancer using qRT-PCR |
Verf.angabe: | Sara Notaro, Daniel Reimer, Michaela Duggan-Peer, Heidi Fiegl, Annamarie Wiedermair, Julia Rössler, Peter Altevogt, Christian Marth, Alain Gustave Zeimet |
E-Jahr: | 2016 |
Jahr: | May 24, 2016 |
Umfang: | 12 S. |
Fussnoten: | Gesehen am 25.06.2019 |
Titel Quelle: | Enthalten in: OncoTarget |
Ort Quelle: | [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 7(2016), 26, Seite 40221-40232 |
ISSN Quelle: | 1949-2553 |
Abstract: | Background: Management of endometrial carcinoma (EC) still needs improvement of risk assessment. Recently, L1CAM immunohistochemical (IHC) evaluation showed a unique value to predict the outcome of early EC. However IHC results are often conflicting for lack of inter-laboratory standardisation. Methods: Here, as a proof of concept and to increase reproducibility we assayed eighty-two EC and 26 normal endometrium samples for L1CAM expression (L1CAMEXP) via qRT-PCR. The IHC evaluation was performed in 50 cancer samples. Moreover, we aimed to substantiate the in-vitro findings of L1CAM regulation through its promoter methylation (L1CAMMET), miR-34a expression and miR-34a promoter methylation. DNA methylation was assessed with MethyLight PCR technique. Results: High overall concordant results between IHC and RT-PCR evaluations were found. L1CAMEXP was detected in 11% of cancer specimens. These positive cancers exhibited a worse DFS (p=0.032) and OS (p=0.016) in a multivariate COX-regression model. L1CAMEXP predicted distant failure (p=0.007) and L1CAMMET predicted risk-reduction of lymph-node involvement (p=0.005). Inverse correlations between L1CAMEXP and L1CAMMET (p=0.004) and between L1CAMEXP and miR-34a expression (p=0.002) were found. Conclusions: In conclusion qRT-PCR analysis is a reliable approach to evaluate L1CAM status in EC and L1CAMEXP was highly predictive for distant failure and poor outcome, confirming the large IHC-based studies. Interestingly, L1CAMMET was able to assess the risk of pelvic lymph-node involvement. Especially the latter finding has to be confirmed in larger prospective series. |
DOI: | doi:10.18632/oncotarget.9574 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.18632/oncotarget.9574 |
| Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=9574&path[]=29971 |
| DOI: https://doi.org/10.18632/oncotarget.9574 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1667900072 |
Verknüpfungen: | → Zeitschrift |
Evaluating L1CAM expression in human endometrial cancer using qRT-PCR / Notaro, Sara [VerfasserIn]; May 24, 2016 (Online-Ressource)
68401053